Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same

2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same

US Patent 9758508 · Granted Sep 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound as a UBR box domain ligand2025
Cargo delivery system and composition comprising the same2025
Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acce2025
Benzyloxy pyridine derivatives and uses thereof2023
Protein transduction domain, fusion compound containing the same, and pharmaceut2023
Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydro2023
Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment 2023
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceut2022
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceut2022
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceut2022
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceut2022
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceut2022